Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Nantahala Capital Management, LLC reported a 5.29% stake in Trisalus Life Sciences, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Nantahala Capital Management, LLC reported a 5.29% stake in Trisalus Life Sciences, Inc., 2,000,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 5.29%
- Shares
- 2,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 5.29% | 2,000,000 |
| Wilmot B. Harkey | 5.29% | 2,000,000 |
| Daniel Mack | 5.29% | 2,000,000 |
Source
Related
- Trisalus Life Sciences, Inc.
- Nantahala Capital Management, LLC
- Trisalus Life Sciences, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Nov 14, 2025
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Form 4 · Szela Mary T · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026